FDA Approves First ALS Autologous Stem Cell Trial

January 21, 2010

The U.S. Food and Drug Administration (FDA) has approved Covington, La.-based TCA Cellular Therapy’s adult stem cell protocol to conduct Phase I clinical trials to assess the safety of a proposed treatment for amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease).

This is the second FDA-approved protocol for the treatment of ALS using stem cells in the country, and the first using adult stem cells from the same patient.

Click on this link to read the complete article:

http://www.stemcellresearchnews.com/absolutenm/anmviewer.asp?a=1947&z=9

Advertisements

One Response to “FDA Approves First ALS Autologous Stem Cell Trial”

  1. Sue said

    Thank G-d this is starting to open up a bit in the USA. How much time we lost, but no use crying over spilt milk. Looking forward and trying to heal the damage one vote at a time.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: